EP1019063A4 - Modulation de reactions immunitaires - Google Patents

Modulation de reactions immunitaires

Info

Publication number
EP1019063A4
EP1019063A4 EP98946998A EP98946998A EP1019063A4 EP 1019063 A4 EP1019063 A4 EP 1019063A4 EP 98946998 A EP98946998 A EP 98946998A EP 98946998 A EP98946998 A EP 98946998A EP 1019063 A4 EP1019063 A4 EP 1019063A4
Authority
EP
European Patent Office
Prior art keywords
modulation
immune responses
immune
responses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98946998A
Other languages
German (de)
English (en)
Other versions
EP1019063A1 (fr
Inventor
Carl John Landauer
Preez Gabriel Johannes Du
Volker Reinhard Schillack
Derrick Cecil Attfield
Den Bogaerde Johannes Beye Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FRANGOLD HOLDINGS Ltd
Original Assignee
FRANGOLD HOLDINGS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FRANGOLD HOLDINGS Ltd filed Critical FRANGOLD HOLDINGS Ltd
Publication of EP1019063A1 publication Critical patent/EP1019063A1/fr
Publication of EP1019063A4 publication Critical patent/EP1019063A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP98946998A 1997-09-16 1998-09-16 Modulation de reactions immunitaires Withdrawn EP1019063A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA9708319 1997-09-16
ZA978319 1997-09-16
PCT/US1998/019126 WO1999013885A1 (fr) 1997-09-16 1998-09-16 Modulation de reactions immunitaires

Publications (2)

Publication Number Publication Date
EP1019063A1 EP1019063A1 (fr) 2000-07-19
EP1019063A4 true EP1019063A4 (fr) 2003-09-03

Family

ID=25586589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98946998A Withdrawn EP1019063A4 (fr) 1997-09-16 1998-09-16 Modulation de reactions immunitaires

Country Status (10)

Country Link
EP (1) EP1019063A4 (fr)
JP (1) JP2001516721A (fr)
CN (1) CN1279612A (fr)
AU (1) AU737867B2 (fr)
BR (1) BR9812321A (fr)
CA (1) CA2304119A1 (fr)
IL (1) IL135091A0 (fr)
NO (1) NO20001341L (fr)
NZ (1) NZ503418A (fr)
WO (1) WO1999013885A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324631A1 (fr) * 2000-10-26 2002-04-26 Virodene Pharmaceutical Holdings (Proprietary) Limited Substance ou composition pour le traitement du cancer
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2203456A1 (fr) * 1996-04-23 1997-10-23 Harry Richardson Elden Composition analgesique topique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2203456A1 (fr) * 1996-04-23 1997-10-23 Harry Richardson Elden Composition analgesique topique
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
ABRAMS J S ET AL: "Phase II trial of N- methylformamide in advanced renal cancer.", AMERICAN JOURNAL OF CLINICAL ONCOLOGY, (1989 FEB) 12 (1) 41-2., XP008019185 *
BUFALO DEL D ET AL: "N-METHYLFORMAMIDE INDUCES CHANGES ON ADHESIVE PROPERTIES AND LUNG-COLONIZING POTENTIAL OF M14 MELANOMA CELLS", BRITISH JOURNAL OF CANCER, LONDON, GB, vol. 77, no. 2, January 1998 (1998-01-01), pages 210 - 215, XP001023799, ISSN: 0007-0920 *
CORDEIRO R F ET AL: "ROLE OF GLUTATHIONE DEPLETION IN THE MECHANISM OF ACTION OF N-METHYLFORMAMIDE AND N,N-DIMETHYLFORMAMIDE IN A CULTURED HUMAN COLON CARCINOMA CELL LINE", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 46, no. 3, March 1986 (1986-03-01), pages 1297 - 1305, XP001023787, ISSN: 0008-5472 *
DATABASE WPI Section Ch Week 199916, Derwent World Patents Index; Class A96, AN 1998-541805, XP002246940 *
JINDAL S K ET AL: "Incidence and recognition of interstitial pulmonary fibrosis in developin countries.", CURRENT OPINION IN PULMONARY MEDICINE, (1997 SEP) 3 (5) 378-83. REF: 51, XP008019184 *
MINIKKAM SUTHANTHIRAN ET AL: "IMMUNOSUPPRESSIVE PROPERTIES OF POLAR ORGANIC COMPOUNDS THAT INDUCECELLULAR DIFFERENTIATION IN FRIEND ERYTHROLEUKEMIA CELLS", TRANSPLANTATION, WILLIAMS AND WILKINS, BALTIMORE, MD, US, vol. 33, no. 5, 1 May 1982 (1982-05-01), pages 534 - 540, XP000560858, ISSN: 0041-1337 *
MISRA, A N. ET AL: "Transdermal administration of insulin: effect of various penetration enhancers", INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY (1996), 34(2), 171-3, XP008019191 *
POELMANS L ET AL: "[Toxic hepatitis due to dimethylformamide: case reports and literature review]. Toxische hepatitis op dimethylformamide: case reports en literatuurgegevens.", ACTA CLINICA BELGICA, (1996) 51 (5) 360-6., XP008019186 *
SCOTLANDI K ET AL: "PRE-TREATMENT OF HUMAN OSTEOSARCOMA CELLS WITH N-METHYLFORMAMIDE ENHANCES P-GLYCOPROTEIN EXPRESSION AND RESISTANCE TO DOXORUBICIN", INTERNATIONAL JOURNAL OF CANCER, NEW YORK, NY, US, vol. 58, no. 1, 1994, pages 95 - 101, XP001023781, ISSN: 0020-7136 *
See also references of WO9913885A1 *

Also Published As

Publication number Publication date
NO20001341L (no) 2000-05-16
NO20001341D0 (no) 2000-03-15
BR9812321A (pt) 2000-09-05
WO1999013885A1 (fr) 1999-03-25
NZ503418A (en) 2001-02-23
CN1279612A (zh) 2001-01-10
EP1019063A1 (fr) 2000-07-19
IL135091A0 (en) 2001-05-20
AU737867B2 (en) 2001-09-06
JP2001516721A (ja) 2001-10-02
AU9389098A (en) 1999-04-05
CA2304119A1 (fr) 1999-03-25

Similar Documents

Publication Publication Date Title
AP9701056A0 (en) Induction of cyctotoxi T-lymphocite responses
GR3035103T3 (en) Clip-type carrier
HK1021561A1 (en) Cooking device
EP1033994A4 (fr) Methodes de preparation de bioginko
SI0958282T1 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
ZA958634B (en) Cookware
IL128152A0 (en) Cooking aid
IL135091A0 (en) Modulation of immune responses
ZA988454B (en) Modulation of immune responses
GB2323652B (en) Means of assembly
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
TW377910U (en) Combination of multiple-contacts connector
GB9726147D0 (en) Antigens
GB9717437D0 (en) Immune modulating agents
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
GB9824723D0 (en) Immune modulating agents
GB9817955D0 (en) Immune modulating agents
CA80165S (en) Saucepan
CA80162S (en) Saucepan
CA80163S (en) Saucepan
CA80164S (en) Saucepan
IL119334A0 (en) Modified cytostatics
GB9708312D0 (en) Protein phosphatase modulation
GB9507655D0 (en) Secure carrier of food

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000413

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030717

17Q First examination report despatched

Effective date: 20031124

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040605